Hundreds of cancer papers mention cell lines that don ’t seem to exist
Research integrity sleuths may have found a new red flag for identifying fraudulent papers, at least in cancer research: Findings about human cell lines that apparently do not exist. That’s the conclusion of a recent study investigating eight cell lines that are consistently misspelled across 420 papers published from 2004 to 2023, including in highly ranked journals in cancer research. Some of the misspellings may have been inadvertent errors, but a subset of 235 papers provided details about seven of the eight lines that indicate the reported experiments weren’t actually conducted, the sleuths say. “Unfortuna...
Source: ScienceNOW - May 21, 2024 Category: Science Source Type: news

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
More than half of all U.S. cervical cancer patients are underscreened1, which makes reducing barriers to sample collection and increasing access to screenings crucial to ultimately helping eliminate this deadly disease.Each year in the U.S., more than 13,000 patients are diagnosed with cervical cancer and approximately 4,000 die from this preventable disease, caused by HPV infection.1Roche ’s human papillomavirus (HPV) self-collection solution will improve access to testing by providing women the option to privately collect their own sample.Basel, 15 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the FDA a...
Source: Roche Media News - May 15, 2024 Category: Pharmaceuticals Source Type: news

Novel'Power-Wash' Procedure May Help Detect Gastric Cancer Novel'Power-Wash' Procedure May Help Detect Gastric Cancer
In proof-of-concept study, high-pressure liquid spray showed promise for collecting cytology specimens from the stomachs of patients undergoing endoscopy for gastric cancer screening or surveillance.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2024 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Muscle cramp compound may drive deadly wasting in cancer patients
“The flesh is consumed and becomes water … the abdomen fills with water, the feet and legs swell, the shoulders, clavicles, chest, and thighs melt away. … The illness is fatal.” This spine-chilling description, written by Greek physician and philosopher Hippocrates, is believed to be the first account of a deadly muscle wasting disease called cachexia (pronounced kuh-KEK-sia). Scientists estimate that up to 80% of cancer patients suffer from the condition, where the body relentlessly eats away at itself until organs such as the heart and diaphragm stop working. Even if cachexia doesn’t directly kill a patie...
Source: ScienceNOW - April 3, 2024 Category: Science Source Type: news

The Scientist’s Journal Club: Neuroscience and Cell Biology
Scientists discuss their latest findings on cell secretory states, synapse formation, and neurodegenerative disease. (Source: The Scientist)
Source: The Scientist - March 20, 2024 Category: Science Tags: The Scientist University Sponsored Webinars Source Type: news

UCLA Samueli to lead $4 million cell research project funded by Chan Zuckerberg Initiative
Key takeawaysThe grant will fund a three-year collaboration among researchers at UCLA, USC and Caltech to advance cell and tissue engineering technologies.The project, led by UCLA ’s Dino Di Carlo, will engineer, manipulate and analyze cell-to-cell interactions that underlie complex multicellular systems in the body.Di Carlo said he aims for the collaboration to develop into a long-term partnership across institutions to advance biotechnology in Los Angeles.The Chan Zuckerberg Initiativetoday announced a $4 million grant to support research led by the UCLA Samueli School of Engineering that will examine cellular behavio...
Source: UCLA Newsroom: Health Sciences - February 29, 2024 Category: Universities & Medical Training Source Type: news

Hologic AI-powered cancer screening system wins FDA approval
The digital cytology system helps identify cervical cancer cells and precancerous lesions using deep learning AI and volumetric imaging technology. (Source: mobihealthnews)
Source: mobihealthnews - February 9, 2024 Category: Information Technology Source Type: news

Cell biologist whose work spans over 30 years receives RMS Scientific Achievement Award
David Stephens, Emeritus Professor of Cell Biology in the School of Biochemistry, has been awarded the Royal Microscopical Society (RMS) Scientific Achievement Award for his work on cell biology. (Source: University of Bristol news)
Source: University of Bristol news - February 7, 2024 Category: Universities & Medical Training Tags: Grants and Awards, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry; Press Release Source Type: news

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer
(MedPage Today) -- Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology) Hologic announced FDA clearance of a digital cytology system... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2024 Category: Hematology Source Type: news

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024 -- (Healthcare Sales & Marketing Network) -- BD (Becton... Diagnostics, Oncology BD , Techcyte, cervical cancer, Pap smear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2024 Category: Pharmaceuticals Source Type: news

Optimal Follow-up After Cervical Cancer Surgery Optimal Follow-up After Cervical Cancer Surgery
Instead of using a one-size-fits-all approach, monitoring for cancer recurrence after fertility-sparing cervical cancer surgery can be tailored based on HPV testing and cytology.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 3, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Researcher loses disability lawsuit against major science funder
A jury in Maryland today delivered a unanimous verdict in favor of the Howard Hughes Medical Institute (HHMI), finding it did not discriminate against Vivian Cheung, a disabled biologist and physician, when it failed to renew her multimillion-dollar award in 2018. The closely watched case put a spotlight on obstacles faced by disabled scientists. Lawyer Chong Park of Ropes & Gray was successful in persuading a jury of four women and two men that HHMI and its reviewers treated Cheung like any other scientist when she competed unsuccessfully to renew her investigator award for RNA studies. At the end of an 8-day tr...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news

Cyclacel Pharmaceuticals Announces Reverse Stock Split
BERKELEY HEIGHTS, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. CYCCCYCCP ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it will implement a 1-for-15 Reverse Stock Split…#berkeleyheights #cyclacel #nasdaqcapitalmarket #cycc #reversestocksplit #equinititrustcompany #llc #cdk29 #plk1 #allrightsreserved (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news

FDA Approves First CRISPR Treatment in U.S.
It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing that the pair earned the Nobel Prize in Chemistry in 2020 for how it could transform the way genetic diseases are treated. Now, on Dec. 8, the U.S. Food and Drug Administration (FDA) approved the very first treatment in the country based on the technology. [time-brightcove not-tgx=”true”] In the medical world, that’s lightning speed. “It’s incredible,” says Doudna, professor of chemistry a...
Source: TIME: Health - December 8, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

USPSTF-recommended screening leads to less cancer burden
Increasing use of recommended screening strategies could reduce the U.S. cancer burden, according to research published November 22 in JAMA Network Open. A team led by Amy Knudsen, PhD, from Massachusetts General Hospital in Boston found an increase of 10 percentage points in the uptake of lung, colorectal, breast, and cervical cancer screening at their respective starting ages as recommended by the U.S. Preventive Services Task Force (USPSTF) led to decreased cancer deaths. It highlighted that this could help the U.S. achieve the Cancer Moonshot initiative’s goals. “Achieving these reductions is predicated on ensuri...
Source: Headlines - November 22, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Imaging Source Type: news